Heart Attack Damage: Scar Tissue Replaces Lost Cardiomyocytes

Adult mammalian cardiomyocytes have minimal regenerative capacity. After myocardial infarction (MI), necrotic myocytes are replaced by fibrotic scar tissue composed of fibroblasts, collagen (types I and III), and extracellular matrix.

Consequences of Scar Formation

  • Loss of contractile function: Scar does not shorten or generate force.
  • Ventricular remodeling: Dilatation, wall thinning, spherical distortion → increased wall stress (Laplace's law) → progressive heart failure.
  • Arrhythmogenic substrate: Scar border zones have heterogeneous conduction → reentrant ventricular tachycardia.
  • Aneurysm formation: Dyskinetic bulge in akinetic segment.

Regenerative Research

  • Cell therapy: MSCs, cardiac progenitor cells, iPSC-derived cardiomyocytes—modest benefit in trials; engraftment/electromechanical integration remain challenges.
  • Direct reprogramming: Fibroblasts → induced cardiomyocytes (GMT, Hand2 transcription factors) in vivo.
  • Mitogenic stimuli: Neuregulin, periostin, miR-199a/590 to induce cardiomyocyte proliferation.
  • Tissue engineering: Epicardial patches, bioartificial myocardium.

Clinical Implications

Early reperfusion (PCI, thrombolysis) limits infarct size. Guideline-directed medical therapy (GDMT: ACEi/ARB/ARNI, beta-blocker, MRA, SGLT2i) attenuates remodeling. ICD for primary prevention if LVEF ≤35% after 3 mo GDMT.

Heart Attack - Related Articles